← Leaderboards
John A. Katzenellenbogen
University Of Illinois Urbana-Champaign
$15,325,493
Attributed
$17,186,590
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$17,186,590 · 6
By mechanism
R01$8,577,728 · 3
R37$7,016,633 · 2
P01$1,592,229 · 1
Top collaborators
- Benita S Katzenellenbogen6 shared
- Kendall W Nettles6 shared
Most similar at University Of Illinois Urbana-Champaign
Same institution · by research overlap
- David J Shapiro$9,694,095
- Benita S Katzenellenbogen$5,921,292
- Ann Nardulli$6,435,714
- Steven C. Zimmerman$7,523,770
Others in their field
Top investigators on “Estrogen Receptors”
- Susan E. Hankinson · University Of Massachusetts Amherst$30,736,590
- David Heimbrook · Leidos Biomedical Research, Inc.$29,594,272
- Bert W O'Malley · Baylor College Of Medicine$28,464,172
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Howard N Hodis · University Of Southern California$24,496,214
- Donald P McDonnell · Duke University$19,513,822
Research focus
Estrogen ReceptorsLigandsEstrogensBaseDesignMolecularReceptorNuclear ReceptorsMalignant Breast NeoplasmStructureLeadResistanceLigand Binding DomainEstrogen AntagonistsTamoxifenHormone TherapyHormonesAgonistSelective Estrogen Receptor ModulatorsIn VivoMolecular ModelingSignal TransductionEstradiolAnimal Model
Grant awards (46)
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$548,236
R01 · FY2022 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$559,423
R01 · FY2021 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$1
R01 · FY2021 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$559,424
R01 · FY2020 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$542,640
R01 · FY2019 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$581,922
R01 · FY2018 · CA
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers$420,805
R01 · FY2017 · CA · contact PI
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers$419,409
R01 · FY2016 · CA · contact PI
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor Activity$396,361
R01 · FY2016 · DK · contact PI
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers$418,051
R01 · FY2015 · CA · contact PI
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor Activity$396,361
R01 · FY2015 · DK · contact PI
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor Activity$396,361
R01 · FY2014 · DK · contact PI
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers$349,318
R01 · FY2014 · CA · contact PI
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers$442,496
R01 · FY2013 · CA · contact PI
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor Activity$411,011
R01 · FY2013 · DK · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$368,097
R37 · FY2012 · DK · contact PI
Radiopharmaceuticals for Breast Tumor Imaging and Therapy$424,117
R01 · FY2011 · CA · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$362,731
R37 · FY2011 · DK · contact PI
Radiopharmaceuticals for Breast Tumor Imaging and Therapy$438,152
R01 · FY2010 · CA · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$361,136
R37 · FY2010 · DK · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$126,676
R37 · FY2010 · DK · contact PI
Radiopharmaceuticals for Breast Tumor Imaging and Therapy$429,685
R01 · FY2009 · CA · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$369,037
R37 · FY2009 · DK · contact PI
Radiopharmaceuticals for Breast Tumor Imaging and Therapy$417,167
R01 · FY2008 · CA · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$365,562
R37 · FY2008 · DK · contact PI
PHYTOESTROGEN ACTION THROUGH ESTROGEN RECEPTORS a & B$348,240
P01 · FY2008 · AG · contact PI
Radiopharmaceuticals for Breast Tumor Imaging and Therapy$426,788
R01 · FY2007 · CA · contact PI
PHYTOESTROGEN ACTION THROUGH ESTROGEN RECEPTORS a & B$346,562
P01 · FY2007 · AG · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$303,161
R37 · FY2007 · DK · contact PI
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING & THERAPY$350,199
R37 · FY2006 · CA · contact PI
MOLECULAR PROBES FOR STEROID RECEPTORS$312,537
R37 · FY2006 · DK · contact PI
PHYTOESTROGEN ACTION THROUGH ESTROGEN RECEPTORS a & B$301,466
P01 · FY2006 · AG · contact PI
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPY$358,937
R37 · FY2005 · CA
MOLECULAR PROBES FOR STEROID RECEPTORS$320,377
R37 · FY2005 · DK
PHYTOESTROGEN ACTION THROUGH ESTROGEN RECEPTORS a &B$299,178
P01 · FY2005 · AG
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPY$372,487
R37 · FY2004 · CA
MOLECULAR PROBES FOR STEROID RECEPTORS$318,967
R37 · FY2004 · DK
PHYTOESTROGEN ACTION THROUGH ESTROGEN RECEPTORS a &B$296,783
P01 · FY2004 · AG
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPY$389,812
R37 · FY2003 · CA
MOLECULAR PROBES FOR STEROID RECEPTORS$353,858
R37 · FY2003 · DK
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPY$378,992
R37 · FY2002 · CA
MOLECULAR PROBES FOR STEROID RECEPTORS$290,671
R37 · FY2002 · DK
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPY$368,486
R37 · FY2001 · CA
MOLECULAR PROBES FOR STEROID RECEPTORS$282,426
R37 · FY2001 · DK
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPY$358,285
R37 · FY2000 · CA
MOLECULAR PROBES FOR STEROID RECEPTORS$304,199
R37 · FY2000 · DK